Clinical trial

Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia

NCT01351428

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Nifedipine Normalized identity: nifedipineView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-12-01

PhaseNA

Conditions

Pre-Eclampsiaverified · MONDO: preeclampsia

Pregnancyunresolved

Hypertensionunresolved

Interventions

NifedipineDRUG · verified · RxNorm: nifedipine

Sponsors & collaborators

Samuel Lunenfeld Research Institute, Mount Sinai Hospitallead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01351428 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.